Molecular pathology of thyroid cancer: diagnostic and clinical implications

This publication has 116 references indexed in Scilit:

• Phase II Trial of Sorafenib in Advanced Thyroid Cancer
  Journal of Clinical Oncology, 2008
• Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer
  Endocrine-Related Cancer, 2008
• BRAFV600E Mutation Is Associated with Preferential Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibition in Thyroid Cancer Cell Lines
  The Journal of Clinical Endocrinology & Metabolism, 2008
• Identification of Genes Differentially Expressed in Benign versus Malignant Thyroid Tumors
  Clinical Cancer Research, 2008
• Dysregulation of the Phosphatidylinositol 3-Kinase Pathway in Thyroid Neoplasia
  Endocrinology and Metabolism Clinics of North America, 2008
• Thyroid carcinoma: molecular pathways and therapeutic targets
  Laboratory Investigation, 2008
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
  Nature, 2007
• Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors
  Proceedings of the National Academy of Sciences, 2007
• Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
  JAMA, 2006
• RET rearrangements in post-Chernobyl papillary thyroid carcinomas with a short latency analysed by interphase FISH
  British Journal of Cancer, 2006